John Buse, MD
Enriched profileVerne S. Caviness Distinguished Professor of Medicine; Chief, Division of Endocrinology and Metabolism; Director, UNC Diabetes Center; Director, NC Translational and Clinical Sciences Institute; Executive Associate Dean for Clinical Research · University of North Carolina School of Medicine
John Buse is Verne S. Caviness Distinguished Professor of Medicine; Chief, Division of Endocrinology and Metabolism; Director, UNC Diabetes Center; Director, NC Translational and Clinical Sciences Institute; Executive Associate Dean for Clinical Research at University of North Carolina School of Medicine. OpenAlex indexes 1,053 publications with 112,874 citations (h-index 141); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory. Clarivate lists John Buse as a Highly Cited Researcher (Clinical Medicine, 2014, 2019-2025).
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
John Buse, MD, is Verne S. Caviness Distinguished Professor of Medicine at University of North Carolina School of Medicine. The public record shows 1,053 publications with 112,874 citations (h-index 141), centered on Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 15 companies, 7 NIH-funded awards (1997–2023).
- Most recent indexed publication: 2026 · Diabetes care
- Top research focus: Diabetes Treatment and Management
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 108 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 492.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Deputy Editor
Diabetes Care (American Diabetes Association journal)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org ↗ - Editorial board member
Diabetes Technology & Therapeutics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →home.liebertpub.com ↗ - Editorial board member
Diabetes, Obesity and Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dom-pubs.onlinelibrary.wiley.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Sponsor: GentiBio, Inc
- Rare and Atypical Diabetes Network
Sponsor: University of South Florida
- The Insulin-Only Bionic Pancreas Pivotal Trial
Sponsor: Jaeb Center for Health Research
Industry payments
Updated 14 Oct 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year202510 payments$25,029openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202513 payments$16,616openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20253 payments$11,514openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
50.1%Biguanide (metformin)14.8%Metformin Hcl70%Metformin Hcl Er30%Part D<11 patientsInsulin Analog13.2%Tresiba Flextouch U-10027%Lantus Solostar20%Tresiba Flextouch U-20013%Novolog Flexpen10%Lantus8%Humalog Kwikpen U-1008%Humalog7%Insulin Lispro7%Part D<11 patients+ 4 more classes in this area
Cardiovascular
37.9%Statin18.7%Atorvastatin Calcium52%Rosuvastatin Calcium41%Simvastatin7%Part D<11 patientsAngiotensin receptor blocker (ARB)4.3%Losartan Potassium100%Part D≥15 patients+ 7 more classes in this area
Hormonal (systemic)
8.2%l-Thyroxine8.2%Levothyroxine Sodium69%Synthroid31%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
7 NIH research awards on record, funded 1997–2023 per NIH RePORTER. The latest:
- North Carolina Translational and Clinical Sciences Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2023$10,042,058UM1TR004406 - North Carolina Translational and Clinical Science Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2022$9,945,630UL1TR002489 - North Carolina Translational and Clinical Science Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2022$218,324UL1TR002489
Congress activity
Updated 14 Oct 2026
47 congress contributions (2018–2026) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 1249-OR: Medically Tailored Meals Lower Hemoglobin A1c: The Food as Medicine for Diabetes (FAME-D) Randomized Clinical Trial
ADA Scientific Sessions
ADA2026Co-authorOral - 2970-LB: High Prevalence of Endogenous Hypercortisolism in Patients with Type 2 Diabetes and Resistant Hypertension: Results from the MOMENTUM Study
ADA Scientific Sessions
ADA2026Co-authorLate-breaking - 155-OR: Reduced Perceived Diabetes Distress with the Omnipod 5 Automated Insulin Delivery (AID) System in Adults with Type 2 Diabetes (T2D)—Analysis of the SECURE-T2D Study
ADA Scientific Sessions
ADA2025Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.
Diabetes, obesity & metabolism
Letter2026 - GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women.
JCO oncology practice
Article2026
Most-cited works
by citation count (OpenAlex)- 01Effects of Intensive Glucose Lowering in Type 2 Diabetes7,899 citations2008
- 02Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes7,395 citations2016
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/john-buse-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
med.unc.edu/medicine/endocrinology-metabolism/people/john-buse-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Other
ncbi.nlm.nih.gov/myncbi/john%20b.buse.1/bibliography/public
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ncbi.nlm.nih.gov ↗ - LinkedIn
linkedin.com/in/john-buse-5227a81b7
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/John-B-Buse-39324232
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
music.amazon.com/podcasts/dfe4cd1a-2f96-4edc-ade2-2c6c70072a82/episodes/213f12c2-6356-46ca-9bc8-6807b85301cd/raise-the-line-the-story-behind-the-%E2%80%98miracle%E2%80%99-of-glp-1-medications-dr-john-buse-chief-of-endocrinology-at-university-of-north-carolina-school-of-medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →music.amazon.com ↗ - Other
med.unc.edu/medicine/news/chairs-corner/podcast/diabetes-care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- BA
Biochemistry, Dartmouth College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - MD
Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - PhD
Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Internal Medicine Internship and Residency
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Endocrinology Fellowship
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership roles
journal and society appointments- Chief
Division of Endocrinology and Metabolism, UNC School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Director
UNC Diabetes Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Director
NC Translational and Clinical Sciences Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientcareonline.com ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20142019202020212022202320242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unchealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- Podcast: "The Story Behind the 'Miracle' of GLP-1 Medications"
Raise the Line, Oct 28, 2025 (Episode 551)
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - HCPLive Endocrinology podcast segment on CATALYST Trial
Mifepristone, and Hypercortisolism in Type 2 Diabetes, recorded at ADA 2025
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - "Diabetes Discussion with Dr. John Buse"
UNC Department of Medicine podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH